Managing Partner, Louis Frapporti, sits down with Chief Executive Officer of McMaster Innovation Park, Ty Shattuck, to discuss Canada's premier research park, how it connects Hamilton's
Norton Rose Fulbright Canada LLP
On October 16, 2020, the Minister of Health (the Minister) signed the Interim Order Respecting the Prevention and Alleviation of Shortages of Drugs in Relation to Covid-19 (the IO)...
Smart & Biggar
This morning, the PMPRB released the final Guidelines operationalizing the amended Patented Medicines Regulations (Amended Regulations).
Amid this year's disruptions to IP litigation, we have seen high-impact developments affecting life sciences companies.
Crowe MacKay LLP
Starting your own business entails a multitude of decisions which can seem overwhelming without the right players on your team. In order to succeed, you need to equip yourself with every tool
Borden Ladner Gervais LLP
Our second session will provide an overview of the regulatory environment and what we're seeing from an international markets perspective.
The future of life sciences in Canada
Arnold & Porter
China has proposed a new rule framing a drug patent linkage system that will have significant impact on multinational pharmaceutical companies doing business in China
COVID-19 Key EU Developments, Policy & Regulatory Update No. 16.
COVID-19 Key EU Developments, Policy & Regulatory Update No. 17.
COVID-19 Key EU Developments, Policy & Regulatory Update No. 18.
COVID-19 Key EU Developments, Policy & Regulatory Update No. 19.
At long last, the new French health care anti-gift regime, modified in 2017, should be applicable as of October 1, 2020, thanks to implementing regulations adopted over the summer.
Last year, in November 2019, a High- Level Committee (HLC) on Corporate Social Responsibility (CSR) was set up to review the CSR framework and make recommendations for developing a more robust...
Obhan & Associates
Corporate Social Responsibility (CSR) has been a soft law in most countries and is considered voluntary, self-regulated and beyond the scope of legislation.
These hard corona times shall pass.
Ronan Daly Jermyn
Artificial Intelligence (AI) has enormous potential to transform healthcare but is uncertainty around applicable regulatory frameworks hampering technological advances and creating a lack of trust?
The Medical Device Regulations (‘MDR') represent the most significant overhaul of the existing medical device regulatory framework in 25 years.
BHSM has gained significant experience in advising and assisting clients in navigating these unfamiliar supply chains in recent months.
Yigal Arnon & Co
Did you know that the gynecological speculum was invented in 1845, under dubious circumstances? If you don't know what a speculum is, you're probably, well, a man.